Vaccine News and Research

Latest Vaccine News and Research

Study characterizes SARS-CoV-2 Omicron BA.2.86: New variant under watch

Researchers identify a new SARS-CoV-2 variant, BA.2.86, with enhanced ability to evade immunity but lower infectivity compared to current variants. The study highlights the need for global monitoring due to its potential to become a predominant strain if it gains infectivity through mutations.

6 Sep 2023

Using ChatGPT to address vaccine hesitancy: a promising tool for guiding users to scientific information?

Researchers assessed ChatGPT's ability to address the 50 most common misconceptions about vaccine safety.

6 Sep 2023

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Researchers at Washington University have demonstrated that early life exposure to multiple viruses in house mice dampens the immune response to SARS-CoV-2 vaccinations later in life. The study raises concerns about the applicability of common mouse models in immunological research, suggesting that prior pathogen exposure could be a significant variable in predicting vaccine efficacy.

5 Sep 2023

Monovalent vaccine outperforms bivalent in fighting new Omicron variants

New U.S. study finds mRNA-1273.815, a monovalent vaccine targeting the Omicron XBB.1.5 variant, generates higher neutralizing antibody titers compared to its bivalent counterpart. The study supports updating to an XBB.1.5-based monovalent vaccine for the 2023-24 campaign to combat emerging variants.

5 Sep 2023

World-renowned Diamond Light Source facility to be upgraded through a £500 million investment

A groundbreaking science facility which kickstarted the UK's world leading Covid drug development and has advanced treatments of global health challenges from HIV to malaria and cancer will be upgraded and expanded through a more than £500 million investment, Science and Technology Secretary Michelle Donelan has announced today (Wednesday 6 September).

5 Sep 2023

Novavax's updated XBB.1.5 vaccine shows promising cross-neutralizing antibodies against new COVID-19 variants

The study reveals that Novavax's updated XBB.1.5 vaccine effectively induces cross-neutralizing antibodies against multiple Omicron XBB sub-variants in both mice and non-human primates.

5 Sep 2023

Study supports vaccination for COVID-19 in patients with glomerular diseases

Among 2,055 adults with a wide range of glomerular diseases, the COVID-19 vaccination did not adversely affect kidney function or worsen kidney damage and appeared safe in this population.

5 Sep 2023

Adapted Pfizer/BioNTech COVID-19 vaccine that targets Omicron XBB 1.5 subvariant receives MHRA approval

Approval has today been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for an adapted Pfizer/BioNTech COVID-19 vaccine that targets the Omicron XBB 1.5 subvariant, after it was found to meet the UK regulator's standards of safety, quality and effectiveness.

5 Sep 2023

Mississippi’s cervical cancer deaths indicate broader health care problems

Shementé Jones knew something wasn't right. Her back hurt. She felt pain during sex.

5 Sep 2023

SARS-CoV-2 Eris variant spreads faster and dodges immunity

Study investigates the characteristics of the EG.5.1 "Eris" variant of SARS-CoV-2, finding it more transmissible among hamsters and slightly better at evading immunity compared to the XBB.1.5 variant. The results suggest that these properties could be driving the variant's increasing prevalence in human populations.

5 Sep 2023

Study characterizes SARS-CoV-2 subvariants to inform development of next-generation COVID-19 vaccines

Researchers characterized two novel SARS-CoV-2 XBB variants, EG.5.1 and XBB.2.3.

4 Sep 2023

Coronavirus fusion peptide could be important target for vaccine development

Although the COVID-19 pandemic was the first time most of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s.

4 Sep 2023

ChatGPT can debunk vaccine myths and increase vaccine uptake, study finds

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics.

4 Sep 2023

Students starting school and college in September are at increased risk of serious illnesses

A leading testing expert fears a perfect storm of infections in September as students start at schools and colleges. School closures during Covid lockdowns mean 1-in-8 students starting university this year remains unprotected against meningitis. Concern is growing early symptoms may be confused with freshers’ flu.

4 Sep 2023

Lessons learned from COVID-19 pandemic can help confront future epidemics

Where did COVID-19 originate? Prof Angus Dalgleish shows that the virus that emerged in Wuhan, China in 2019 had been modified in a laboratory to make it more infectious (for the construction of a more effective vaccine).

1 Sep 2023

Activist misuses federal data to make false claim that covid vaccines killed 676,000

A blog post shared on Facebook claimed that covid-19 vaccines have killed some 676,000 Americans.

1 Sep 2023

Scientists delve deeper into how vaccines work against leishmaniasis

Scientists have established the effectiveness of vaccines they developed to prevent the disfiguring skin disease leishmaniasis in animal studies, and Phase 1 human trial planning is in motion for the most promising candidate.

31 Aug 2023

Boosters slow antibody waning but hit a ceiling: Long-term COVID study reveals limits of immunity

The study tracks the long-term kinetics of antibody responses to SARS-CoV-2 after vaccination and infections in New York healthcare workers from 2020 to 2023. It reveals that antibody waning is slower after booster shots, but there's an upper limit to antibody levels, which gradually lowers with repeated SARS-CoV-2 exposures and vaccinations.

31 Aug 2023

Cracking the code on post-vaccine COVID protection

The study investigates the relationship between antibody levels and behavioral factors in 176 adults vaccinated with Pfizer's BNT162b2, finding that higher levels of specific antibodies correlate with greater protection against symptomatic COVID-19. It also suggests that current commercial assays may need reformatting for better risk prediction.

31 Aug 2023

Coronavirus fusion peptide plays more invasive role in infection than previously thought

Although the COVID-19 pandemic was the first time most of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s.

31 Aug 2023

Previous
1
...
58
59
60
61
62
63
64
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

Study characterizes SARS-CoV-2 Omicron BA.2.86: New variant under watch

Using ChatGPT to address vaccine hesitancy: a promising tool for guiding users to scientific information?

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Monovalent vaccine outperforms bivalent in fighting new Omicron variants

World-renowned Diamond Light Source facility to be upgraded through a £500 million investment

Novavax's updated XBB.1.5 vaccine shows promising cross-neutralizing antibodies against new COVID-19 variants

Study supports vaccination for COVID-19 in patients with glomerular diseases

Adapted Pfizer/BioNTech COVID-19 vaccine that targets Omicron XBB 1.5 subvariant receives MHRA approval

Mississippi’s cervical cancer deaths indicate broader health care problems

SARS-CoV-2 Eris variant spreads faster and dodges immunity

Study characterizes SARS-CoV-2 subvariants to inform development of next-generation COVID-19 vaccines

Coronavirus fusion peptide could be important target for vaccine development

ChatGPT can debunk vaccine myths and increase vaccine uptake, study finds

Students starting school and college in September are at increased risk of serious illnesses

Lessons learned from COVID-19 pandemic can help confront future epidemics

Activist misuses federal data to make false claim that covid vaccines killed 676,000

Scientists delve deeper into how vaccines work against leishmaniasis

Boosters slow antibody waning but hit a ceiling: Long-term COVID study reveals limits of immunity

Cracking the code on post-vaccine COVID protection

Coronavirus fusion peptide plays more invasive role in infection than previously thought

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in